Live Breaking News & Updates on Orphan neurological

Stay informed with the latest breaking news from Orphan neurological on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Orphan neurological and stay connected to the pulse of your community

Quince Therapeutics to Participate at Investor Events in January 2024

Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today...

San-francisco , California , United-states , Dirk-thye , Facebook , Nasdaq , Quince-therapeutics-inc , Neuroscience-innovation-forum , Linkedin , Quince-therapeutics , Chief-executive-officer , Chief-medical-officer

Noema Pharma to Present at Two Upcoming Conferences

BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE

San-francisco , California , United-states , Switzerland , Noema-pharma , Neuroscience-innovation-forum , Panel-discussion , Exploring-new-modalities , Orphan-neurological , Trigeminal-neuralgia , Tuberous-sclerosis-complex , Childhood-onset-fluency-disorder